Drug interactions with grapefruit juice: An update

被引：37

作者：

Greenblatt, DJ ^{[1
]}

Patki, KC ^{[1
]}

von Moltke, LL ^{[1
]}

Shader, RI ^{[1
]}

机构：

[1] Tufts Univ, Sch Med, Boston, MA 02111 USA

来源：

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 2001年 / 21卷 / 04期

关键词：

D O I：

10.1097/00004714-200108000-00001

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：357 / 359

页数：3

共 35 条

[1] Grapefruits and drugs: When is statistically significant clinically significant? [J].

Abernethy, DR .

JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (10) :2297-2298

[2] Drug interactions with grapefruit juice [J].

Ameer, B ;

Weintraub, RA .

CLINICAL PHARMACOKINETICS, 1997, 33 (02) :103-121

[3]

BAILEY DG, 1989, CLIN INVEST MED, V12, P357

[4] GRAPEFRUIT JUICE AND DRUGS - HOW SIGNIFICANT IS THE INTERACTION [J].

BAILEY, DG ;

ARNOLD, JMO ;

SPENCE, JD .

CLINICAL PHARMACOKINETICS, 1994, 26 (02) :91-98

[5] Grapefruit juice felodipine interaction:: Effect of naringin and 6′,7′-dihydroxybergamottin in humans [J].

Bailey, DG ;

Kreeft, JH ;

Munoz, C ;

Freeman, DJ ;

Bend, JR .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 64 (03) :248-256

[6] Grapefruit juice-drug interactions [J].

Bailey, DG ;

Malcolm, J ;

Arnold, O ;

Spence, JD .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 46 (02) :101-110

[7] Grapefruit-felodipine interaction: Effect of unprocessed fruit and probable active ingredients [J].

Bailey, DG ;

Dresser, GR ;

Kreeft, JH ;

Munoz, C ;

Freeman, DJ ;

Bend, JR .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 68 (05) :468-477

[8] DISPOSITION OF INTRAVENOUS AND ORAL CYCLOSPORINE AFTER ADMINISTRATION WITH GRAPEFRUIT JUICE [J].

DUCHARME, MP ;

WARBASSE, LH ;

EDWARDS, DJ .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (05) :485-491

[9]

Eagling VA, 1999, BRIT J CLIN PHARMACO, V48, P543, DOI 10.1046/j.1365-2125.1999.00052.x

[10] Naringin and naringenin are not the primary CYP3A inhibitors in grapefruit juice [J].

Edwards, DJ ;

Bernier, SM .

LIFE SCIENCES, 1996, 59 (13) :1025-1030

← 1 2 3 4 →